We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
+12.39%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.62B
AUM Growth
+$99.5M
Cap. Flow
-$24.9M
Cap. Flow %
-1.54%
Top 10 Hldgs %
17.08%
Holding
826
New
61
Increased
333
Reduced
360
Closed
60
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMI icon
26
Cummins
CMI
$87.4B
$10.3M 0.64%
42,583
-1,362
-3% -$324K
SPGI icon
27
S&P Global
SPGI
$121B
$9.8M 0.6%
29,255
-3,224
-10% -$1.06M
MA icon
28
Mastercard
MA
$493B
$9.72M 0.6%
27,943
-5,995
-18% -$1.97M
AMZN icon
29
Amazon
AMZN
$3T
$9.52M 0.59%
113,294
-9,936
-8% -$981K
JNJ icon
30
Johnson & Johnson
JNJ
$631B
$9.43M 0.58%
53,373
+3,631
+7% +$627K
INTF icon
31
iShares International Equity Factor ETF
INTF
$3.74B
$9.4M 0.58%
382,041
+3,380
+0.9% +$79.3K
ODFL icon
32
Old Dominion Freight Line
ODFL
$44.1B
$9.18M 0.57%
64,724
-2,648
-4% -$376K
MRK icon
33
Merck
MRK
$323B
$9.17M 0.57%
82,629
+7,902
+11% +$808K
ADP icon
34
Automatic Data Processing
ADP
$109B
$9.06M 0.56%
37,913
+620
+2% +$152K
UNH icon
35
UnitedHealth
UNH
$371B
$8.89M 0.55%
16,766
-299
-2% -$158K
EVN
36
Eaton Vance Municipal Income Trust
EVN
$429M
$8.85M 0.55%
896,152
+169,553
+23% +$1.67M
COST icon
37
Costco
COST
$423B
$8.74M 0.54%
19,146
-3,884
-17% -$1.9M
V icon
38
Visa
V
$675B
$8.54M 0.53%
41,130
-834
-2% -$168K
HYDB icon
39
iShares High Yield Systematic Bond ETF
HYDB
$1.6B
$8.21M 0.51%
188,509
+7,060
+4% +$308K
TXN icon
40
Texas Instruments
TXN
$256B
$7.86M 0.49%
47,574
-986
-2% -$164K
ELV icon
41
Elevance Health
ELV
$86.2B
$7.84M 0.48%
15,291
-1,519
-9% -$771K
TMO icon
42
Thermo Fisher Scientific
TMO
$222B
$7.81M 0.48%
14,184
-492
-3% -$261K
CSCO icon
43
Cisco
CSCO
$483B
$7.35M 0.45%
154,287
+1,830
+1% +$83.3K
SRLN icon
44
State Street Blackstone Senior Loan ETF
SRLN
$5.35B
$7.34M 0.45%
179,486
+6,164
+4% +$254K
ABT icon
45
Abbott
ABT
$188B
$7.3M 0.45%
66,511
-6,402
-9% -$663K
NAN icon
46
Nuveen New York Quality Municipal Income Fund
NAN
$373M
$7.28M 0.45%
680,792
+131,066
+24% +$1.36M
NRK icon
47
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$916M
$7.2M 0.44%
702,051
+136,476
+24% +$1.37M
AXSM icon
48
Axsome Therapeutics
AXSM
$11.4B
$7.19M 0.44%
93,190
-13,392
-13% -$800K
GOOGL icon
49
Alphabet (Google) Class A
GOOGL
$4.37T
$7.14M 0.44%
80,903
-11,880
-13% -$1.13M
JPM icon
50
JPMorgan Chase
JPM
$956B
$7.1M 0.44%
52,941
-7,108
-12% -$901K

Similar funds

Hennion & Walsh Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Hennion & Walsh Asset Management held 826 positions worth $1.62B, up 6.5% from $1.52B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Hennion & Walsh Asset Management's Q4 2022 filing shows 61 new, 333 increased, 360 reduced and 60 closed positions. Its largest new stake was ConocoPhillips: 5,945 shares worth $702K. The largest sale was Global Blood Therapeutics, Inc., an estimated $8.48M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 15% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q4 2022 buy was ConocoPhillips: 5,945 shares worth $702K.
  • Hennion & Walsh Asset Management added most to iShares Core S&P 500 ETF in Q4 2022, an estimated $7.48M increase.
  • Hennion & Walsh Asset Management's biggest Q4 2022 reduction was Nuveen Municipal Credit Income Fund, cutting an estimated $7.27M.
  • Hennion & Walsh Asset Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $8.48M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 17% of its $1.62B portfolio in Q4 2022.
  • Hennion & Walsh Asset Management opened 61 new positions and closed 60 in Q4 2022.
  • Hennion & Walsh Asset Management's portfolio value rose 6.5% quarter-over-quarter to $1.62B.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.